The ALMS1 gene helps many tissues, including the eyes, ears, heart, and pancreas, work normally. This gene plays an important role in how cells use cilia, tiny projections that help them sense their surroundings. When the ALMS1 gene does not work properly, it can cause Alström syndrome, which may lead to vision and hearing loss, heart problems, insulin resistance, and kidney or liver disease. Symptoms and severity can vary from person to person.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or manage activities in the body. Some genes provide the directions for making proteins, which are the parts of cells that do the work. Others are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medicines. More detailed information on this topic is available in the LearnHub.
Overview
ALMS1Gene function
What if the gene works
The ALMS1 gene helps cells build and maintain cilia, tiny hair-like structures that sense signals and support normal tissue function. It also helps with cell organization and transport inside cells.
Risk
What if the gene does not work
Pathogenic variants in the ALMS1 gene cause Alström syndrome, which often affects vision and hearing and can involve the heart, liver, kidneys, growth, and blood sugar. Milder to severe variants may change when features appear and how marked they are.
Treatment
What does that mean for your treatment
If you carry a pathogenic or loss-of-function variant in the ALMS1 gene, no ALMS1-specific treatment or drug choice is currently established in clinical guidelines. Research on the ALMS1 gene is helping scientists understand ciliopathies and related metabolic changes, but it does not yet guide routine medicines.
Conditions associated with ALMS1
Gene function
What if the gene works
ALMS1 helps cells keep their internal layout organized, especially around cilia, which are tiny projections that sense signals. Its protein is active at the centrosome (the cell’s organizing hub) and the basal body (the anchor point for a cilium). Understanding what the ALMS1 gene does in the body helps show how cells manage routine signaling and transport.
The ALMS1 gene helps build and maintain primary cilia, which are tiny cell projections that sense outside signals. This supports how many cells pick up cues that guide everyday tissue function.
Its protein works at the cell’s organizing hub and near the base of the cilium. This helps cells keep their shape, place key structures correctly, and coordinate routine internal tasks.
ALMS1 supports the movement of proteins and other cell cargo near the base of cilia. This helps important signals and materials reach the right place inside the cell.
During the normal cell cycle, ALMS1 helps coordinate changes around the cell’s organizing hub as a cell gets ready to divide. This supports orderly timing and steady cell maintenance.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help account for normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can affect how a gene works more strongly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ALMS1 gene often make the protein cut short, unstable, or absent, which disrupts its role at the base of cilia (tiny hair-like cell structures that help cells sense signals). This is how ALMS1 gene variants affect protein function in many people with Alström syndrome. Milder variants may leave some activity, while more severe variants can cause near-complete loss, which can influence how early features appear and how broad they are.
How variants are linked to conditions
Pathogenic variants in the ALMS1 gene cause Alström syndrome, a rare inherited condition linked with progressive vision and hearing loss, heart disease, and metabolic problems such as insulin resistance. In most affected people, variants are found in both copies of the ALMS1 gene, which can confirm an ALMS1 gene diagnosis of Alström syndrome. People with one variant are usually carriers and do not develop the full condition.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well understood variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ALMS1, risk is mostly set by inheritance rather than lifestyle. Alström syndrome usually happens when a child inherits two nonworking copies of the ALMS1 gene, so risk is higher when both parents carry an ALMS1 change, and it can also be higher in families where relatives have children together. Lifestyle changes have not been shown to lower the chance of inheriting it.
Inheritance of ALMS1 variants
For families looking into the ALMS1 gene inheritance pattern, ALMS1-related Alström syndrome follows an autosomal recessive pattern. This means a child usually inherits one ALMS1 variant from each parent, and the parents are often healthy carriers. When both parents carry an ALMS1 variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is also a carrier, and a 25% chance of a child with neither variant.
What does my ALMS1 result mean for my family?
For families with an ALMS1-related condition, it usually runs in a recessive pattern, so parents are often healthy carriers and brothers or sisters may also be affected or be carriers. Close relatives may want to learn whether the same gene change is present in the family, especially when planning children. Children of someone with Alström syndrome will usually be carriers unless the other parent also carries an ALMS1 gene change.
Genetic information
Genetic testing
How you find out about variants
ALMS1 genetic testing for Alström syndrome usually uses a blood or saliva sample to read the ALMS1 gene and look for variants. Finding harmful variants in both copies of the gene can confirm the diagnosis in the right clinical setting, while a negative or unclear result may still need careful interpretation.
When should I consider getting a genetic test?
Genetic testing for the ALMS1 gene may be worth considering when someone has signs of Alström syndrome, a rare inherited condition that can affect sight, hearing, the heart, and blood sugar. It can also help clarify the cause when this condition runs in the family.
A genetic result is only one part of your health story
How much a genetic result can tell you depends on the condition and on the type of variant involved, although it can still provide meaningful insight. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Part of the difference comes from how each person’s body breaks down, moves, and responds to a drug. These inherited differences are common and can influence both how well a medicine works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way a person responds to medicines. It studies gene-drug patterns to better understand why the same treatment may work differently from one person to another. For many medications, genes can influence how strong a drug’s effects are or how the body handles it. This information can support more informed and more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the ALMS1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so any concerns about side effects, treatment changes, or your overall health are best discussed with your doctor or pharmacist.
History
Alström syndrome was first described in 1959 by the Swedish physician Carl-Henry Alström, long before the ALMS1 gene itself was identified. Families and communities once noticed patterns that seemed to pass from parent to child. For many years, doctors recognized the condition by its shared features in affected relatives, but the genetic cause remained unclear. In 2002, researchers mapped the condition to the ALMS1 gene and identified disease-causing variants, which marked an important step in confirming the diagnosis at the DNA level. From these first observations, research expanded steadily. This discovery helped connect older clinical reports with modern genetic testing and gave families a clearer explanation for an inherited condition that had been recognized for decades.